| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/09/2011 | US20110135579 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 06/09/2011 | US20110135577 Superparamagnetic nanoparticles IN MEDICAL THERAPEUTICS and manufacturing method THEREOF |
| 06/09/2011 | US20110135571 Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents |
| 06/09/2011 | US20110135568 Thickened beverages for dysphagia |
| 06/09/2011 | US20110132389 Agent for fibers containing keratin, comprising at least one specific amphiphilic cationic polymer, at least one cationic styling polymer that is different therefrom and at least one film-forming non-ionic and/or stabilizing non-ionic polymer |
| 06/09/2011 | US20110132357 Compositions, methods & systems for respiratory delivery of two or more active agents |
| 06/09/2011 | US20110132356 Compositions for pulmonary delivery of long-acting b2 adrenergic receptor agonists and associated methods and systems |
| 06/09/2011 | US20110131928 Reduced-odor thiol compositions |
| 06/09/2011 | US20110131754 Process |
| 06/09/2011 | DE202011000728U1 Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets Pancreatin pellets, especially pancreatin micro pellets |
| 06/09/2011 | DE102009056884A1 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben Vaccine adjuvants and to improved methods for the preparation thereof |
| 06/09/2011 | DE102009056883A1 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben Vaccine adjuvants and to improved methods for the preparation thereof |
| 06/09/2011 | CA2782911A1 Liposome of irinotecan or its hydrochloride and preparation method thereof |
| 06/09/2011 | CA2782751A1 Transdermal therapeutic system for the administration of peptides |
| 06/09/2011 | CA2782741A1 Transdermal therapeutic system for the administration of peptides |
| 06/09/2011 | CA2782683A1 Integrated ingestible event marker system with pharmaceutical product |
| 06/09/2011 | CA2782650A1 Arranging interaction and back pressure chambers for microfluidization |
| 06/09/2011 | CA2782556A1 Amantadine compositions and methods of use |
| 06/09/2011 | CA2782511A1 Circulation of components during homogenization of emulsions |
| 06/09/2011 | CA2782441A1 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection |
| 06/09/2011 | CA2782285A1 Fexofenadine microcapsules and compositions containing them |
| 06/09/2011 | CA2782205A1 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
| 06/09/2011 | CA2782204A1 Suppository for rectal, vaginal or urethral administration containing a probiotic, an antibiotic and an unsaturated non-esterified fatty acid |
| 06/09/2011 | CA2781593A1 Microspheres of hydrolysed starch with endogenous, charged ligands |
| 06/09/2011 | CA2781254A1 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 06/09/2011 | CA2780425A1 Hydrophilic filtration during manufacture of vaccine adjuvants |
| 06/09/2011 | CA2780304A1 Ophthalmic emulsion |
| 06/08/2011 | EP2330194A2 Non-sequence complementary antiviral oligonucleotides |
| 06/08/2011 | EP2330081A2 Oxidative reductive potential water solution, processes for producing same and methods of using the same |
| 06/08/2011 | EP2329861A1 Pharmaceutical products and compositions comprising formoterol, budesonide and ipratropium |
| 06/08/2011 | EP2329849A1 Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
| 06/08/2011 | EP2329828A1 Tetracyclines for the treatment of ischaemia |
| 06/08/2011 | EP2329826A1 Tetracyclines for the treatment of multiple sclerosis |
| 06/08/2011 | EP2329823A1 Method for improving absorbability of preparation, and preparation having improved absorbability |
| 06/08/2011 | EP2329820A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 06/08/2011 | EP2329813A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 06/08/2011 | EP2329812A1 Film-coated scored tablet |
| 06/08/2011 | EP2329811A1 Ocular implant obtained by multiple extrusion process |
| 06/08/2011 | EP2329810A1 Gastric retention drug delivery system, preparation method and use thereof |
| 06/08/2011 | EP2329717A1 Disinfectant and/or bactericidal aqueous compositions |
| 06/08/2011 | EP2329282A1 Mri-visible sutures for minimally invasive image-guided anastomosis |
| 06/08/2011 | EP2329005A1 Apparatus and method for dehydrating biological materials with freezing and microwaving |
| 06/08/2011 | EP2328665A1 Method and product |
| 06/08/2011 | EP2328617A2 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 06/08/2011 | EP2328614A1 Microparticles for use in immunogenic compositions |
| 06/08/2011 | EP2328609A1 Rapidly disintegrating tablets comprising lipase, amylase, and protease |
| 06/08/2011 | EP2328607A1 Stable formulation of a therapeutic protein |
| 06/08/2011 | EP2328601A2 Linaclotide-containing formulations for oral administration |
| 06/08/2011 | EP2328590A1 Topical hydrogel composition |
| 06/08/2011 | EP2328589A1 Treatment of vaginal atrophy in women with tumor pathology risk |
| 06/08/2011 | EP2328587A1 Dosage form comprising 1-isopropyl-4-{ [4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine or a salt thereof |
| 06/08/2011 | EP2328584A2 Treatment of neurological disorders using huperzine |
| 06/08/2011 | EP2328582A1 Transdermal extended-delivery donepezil compositions and methods for using the same |
| 06/08/2011 | EP2328568A1 Chewable formulation comprising alginate, bicarbonate and carbonate |
| 06/08/2011 | EP2328567A2 Continuous fiber layer comprising an active substance on the basis of bio-polymers, the use thereof, and method for the production thereof |
| 06/08/2011 | EP2328566A1 Enzyme composition and application thereof in the treatment of pancreatic insufficiency |
| 06/08/2011 | EP2328565A1 An extended release pharmaceutical composition of entacapone or salts thereof |
| 06/08/2011 | EP2328564A2 Fixed dose combination in form of a bilayered or monolayered tablet of aliskiren and amlodipine |
| 06/08/2011 | EP2328563A1 Solubility enhancing pharmaceutical formulation |
| 06/08/2011 | EP2328562A1 Galenical formulation comprising aliskiren and process for its preparation by melt extrusion granulation |
| 06/08/2011 | EP2328561A2 Rate modulated delivery of drugs from a composite delivery system |
| 06/08/2011 | EP2328560A1 Pharmaceutical solid preparation |
| 06/08/2011 | EP2328559A2 Novel antibody formulation |
| 06/08/2011 | EP2328558A2 Use of sucralose as a granulating agent |
| 06/08/2011 | EP2328557A1 Oral formulations of chemotherapeutic agents |
| 06/08/2011 | EP2328556A2 Formulations containing large-size carrier particles for dry powder inhalation aerosols |
| 06/08/2011 | EP2328555A2 Compositions for the treatment of neoplastic diseases |
| 06/08/2011 | EP2328554A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions |
| 06/08/2011 | EP2328553A1 Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| 06/08/2011 | EP2328552A1 Lipid formulations comprising a thiolated antioxidant |
| 06/08/2011 | EP2328551A1 Stabilized pharmaceutical sub-micron suspensions and methods of forming same |
| 06/08/2011 | EP2328550A1 Mucoadherents compositions and their use |
| 06/08/2011 | EP2328549A2 Sore throat compositions |
| 06/08/2011 | EP2328541A1 A stimulatable asymmetrical polymersome |
| 06/08/2011 | EP2328539A1 Smooth, high solids tablet coating composition |
| 06/08/2011 | EP2328531A1 Bandage for joint pain treatment comprising at least two transdermal patches |
| 06/08/2011 | EP2328530A2 Transdermal delivery of apomorphine using microneedles |
| 06/08/2011 | EP1940383B1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 06/08/2011 | EP1622657B1 Dialysis valve |
| 06/08/2011 | EP1531800B1 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 06/08/2011 | EP1453929B2 Methods of making film structures |
| 06/08/2011 | EP1392255B1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 06/08/2011 | EP1320356B2 Preparation of vitamin emulsions and concentrates thereof |
| 06/08/2011 | EP1259259B1 Mucosal adjuvant formulation |
| 06/08/2011 | EP0996423B1 A method for producing jelly sweets which contain antibodies |
| 06/08/2011 | CN201855440U Faint relieving tape for external use |
| 06/08/2011 | CN201855438U Tablet printed with dose dividing markers |
| 06/08/2011 | CN201855437U Tablet capable of adjusting dose for special crowds |
| 06/08/2011 | CN1989966B Pharmaceutical composition comprising rifamoin and isoniazid |
| 06/08/2011 | CN1973854B Process of preparing motherwort injection |
| 06/08/2011 | CN1958050B Composition of Chinese traditional medicine for treating rickets, and preparation method |
| 06/08/2011 | CN1954873B Traditional Chinese medicine composition and its preparation method |
| 06/08/2011 | CN1943749B A Chinese traditional medicinal composition for treatment of Child's feeblemindedness of and its preparation method |
| 06/08/2011 | CN1931336B Chinese medicine composition and its preparation process |
| 06/08/2011 | CN1931287B Chinese medicine composition for treating piles and its preparation process |
| 06/08/2011 | CN1895322B Jinganmin effervescent tablets and preparation thereof |
| 06/08/2011 | CN1882321B Pellets containing venlafaxine hydrochloride |
| 06/08/2011 | CN1872260B Method for preparing drop pills of ageratum vital qi |
| 06/08/2011 | CN1859898B Compositions for delivering highly water soluble drugs |
| 06/08/2011 | CN1813919B Capsule for treating root and promoting transformation for heptitis B and its preparing process |